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potential tumor suppressor, expression of which is downregu-
lated in various human tumor types. Additionally, Pdcd4 is able
to inhibit the neoplastic transformation in the JB6 mouse model.
Pdcd4 has been shown to inhibit translation of diverse regula-
tory factors important for neoplastic transformation. Moreover,
it was shown that AKT phosphorylates Pdcd4, causing nuclear
translocation and inactivation of the latter. This suggests that
Pdcd4 activity is dependent on its cellular localisation. Up to
now, Pdcd4 protein expression and cellular localisation has not
been analysed in a large series of patients with colorectal cancer
(CRC).
Methods: We investigated the expression pattern and localisa-
tion of Pdcd4 tumor suppressor protein in resected tumor and
corresponding normal tissue in a series of 41 CRC patients (32
R0-resected) who did not receive neoadjuvant treatment, by Wes-
tern blotting (WB) and immunhistochemistry (IHC). A separate
semiquantitative score for ICH staining of the cytoplasm and
nuclei was established. Preliminary analysis of Pdcd4 expression
and localisation was correlated with patient’s clinical tumor stage
(UICC) and with recurrence-free survival.
Results: In WB high overall Pdcd4 amounts were detected in nor-
mal tissue in comparison to the tumor samples where the signal
was significantly decreased (p = 0.025, Wilcoxon). IHC analysis
revealed strong nuclear presence of Pdcd4 in the apical cryptal
epithelium of normal tissue, as opposed to the complete loss of
nuclear expression in tumor tissue (p = 0.001, Wilcoxon). In nor-
mal tissue, loss of Pdcd4 nuclear expression/increase of cytoplas-
mic Pdcd4-staining was significantly associated with advanced
UICC stages (p = 0.027, v2). Preliminary Kaplan–Meier-analysis
(median recurrence-free survival time: 38 months, range: 1–74
months) showed a trend for loss of Pdcd4 expression in the nuclei
of the normal tissue to be associated with poor recurrence-free
survival (p = 0.09, Breslow log rank).
Conclusion: This is the first clinical study that demonstrates a
potential relevance of Pdcd4 expression and localisation in
resected colorectal tumors and corresponding normal tissue, for
tumor diagnosis and progression. Further analysis of colorectal
adenomas will be performed to study the role of Pdcd4 localisa-
tion as a potential clinical marker for carcinogenesis in CRC.
doi:10.1016/j.ejcsup.2006.04.065
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University Hospital, Cre´teil, France.Background: Proteinases activated receptors (PARs) are impor-
tant members of the G protein-coupled receptors family. The
proteolytic cleavage of their extracellular domain by serine pro-
teases such as trypsin or thrombin, generates an autoactivating
tethered-ligand. Thus, the corresponding activated G proteins
trigger a cascade of downstream events leading to diverse cellu-
lar outcomes such as calcium signalling, cell adhesion, cell
migration and mitogenesis. The role of proteases in promoting
invasion of cancer cells and tumorigenesis have prompted us
to study the expression level and localisation of the four known
members of the PARs family and explore their role in cell
proliferation.
Methods: First, by using quantitative RT-PCR, we have quanti-
fied: (i) the expression of each PAR in colon and prostate cancer
cell lines, (ii) the PARs expression in 40 patients samples (colon
or prostate normal tissue and cancer). Second, we have studied
PARs tissue localisation in colon and prostate, by using immuno-
histochemistry staining on TMA samples. Finally, we investigated
the role of the four members of PAR family (PAR1-4) in cell prolif-
eration by stimulating cell lines in different conditions (various
thrombin concentrations).
Results: Our results show that the expression profile of the PARs
is different for each PAR and depend mostly of the cell lines char-
acterisation (origin and stage). However, we demonstrate a con-
stant overexpression of two PARs in every tested cell line, that
was also found in tumor samples.
Immunohistochemichal analysis shows PAR1 endothelial
expression which was stronger in malignant tissues (prostate
and colon samples), and weaker (prostate) or absent (colon) in
normal tissues.
Conclusion: These results confirm the importance of PARs in
cancer, whose expression pattern is likely to influence cancer cell
behaviour in tumors.
doi:10.1016/j.ejcsup.2006.04.066
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Background: Glioblastomas are the most common malignant
brain tumors in adults characterized by very aggressive local growth
and invasiveness. Tumor invasion into surrounding brain tissue is
facilitated by increased expression and activity of matrix metallo-
proteinases (MMPs), which may be marker for tumor aggressive-
ness. However, for several of the 23 human MMPs there are no or
only very limited literature data available concerning expression
by glioblastomas. Therefore, we screened an extensive panel of 15
low-grade astrocytomas and 15 glioblastomas in order to fill the
gaps in our knowledge about MMP expression by these tumors.
Methods: Expression of MMPs was analysed by semiquantitative
RT-PCR and immunostaining. Total RNA was used as template for
RT-PCR. Immunostaining was performed on cryosections.
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showed that MMP-2, -7, -9, -12, -14, -15, and -25 are expressionally
correlated with the tumor grade. The data for MMP-1, -11, -19 and
-24 are contradictory, since some studies, including our own, sug-
gest involvement during brain tumor development, whereas the
results of other groups deny such connection. The remaining
MMPs do not seem to play a major role during glioblastoma devel-
opment, because they are either constitutively expressed or not
expressed at all.
Conclusion: This is the first complete compilation of expression
of all 23 human MMPs by astrocytic tumors. Specific MMP expres-
sion patterns may mark tumor aggressiveness. Expression stud-
ies will extend our understanding of tumor invasiveness and
help us to find more effective therapeutic means for treatment
of glioblastomas.
doi:10.1016/j.ejcsup.2006.04.067
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Background: Carcinogenesis is a multistage process driven by
genetic and epigenetic alterations that are associated with
changes in the expression or function of oncogenes and tumor-
suppressor genes.
Methods: In order to identify novel tumor-associated genes, we
performed global gene expression profiling with specimens of a
well-established multistage tumor model of mouse skin resulting
in a comprehensive list of differentially expressed genes.
Results: One of these genes encodes for the secreted serine pro-
tease Bssp and is characterized by elevated expression in
advanced stages of mouse skin tumors. Moreover, we found
enhanced levels of kallikrein 6, the human homolog, in malignant
squamous skin tumors of human patients as well as in tumors of
other epithelial tissues suggesting a common role in carcinogen-
esis. To unravel the consequence of elevated Bssp expression in
epithelial cells, we established stable transfected keratinocytes
expressing exogenous Bssp. These cells displayed increased pro-
liferation and advanced migration accompanied by impaired
E-cadherin-mediated cell–cell adhesion and increased nuclear b-
catenin localization. Enhanced proliferation of keratinocytes
was confirmed in a wound healing experiment using a transgenic
mouse model with exogenous Bssp expression in skin.
Conclusion: In summary our data imply that elevated Bssp/Klk6
levels support epithelial neoplasia due to modulation of E-cad-
herin/b-catenin signalling and thereby facilitate proliferation
and migration of tumor cells.
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Background: Pancreatic carcinoma is characterized by early
metastasis. Increased cell motility is critical for metastasis of
tumor cells. Cell motility is based on reorganization of the actin
cytoskeleton in lamellipodia at the leading cell edge. Rac is a
Rho-family small GTPase, which regulates rearrangement of the
actin network and is also involved in tumor metastasis. Eps8,
originally identified as a substrate of the epidermal growth factor
receptor (EGFR), serves as a Rac guanine nucleotide exchange fac-
tor thus activating Rac. Eps8 is involved in cancer cell invasive-
ness and motility in fibrosarcoma cells. Eps8 further binds actin
directly and possess barbed end capping activity.
Methods: Pancreatic tissue was obtained from patients that
underwent pancreatic resection at the University of Heidelberg.
Eight pancreatic cancer cell lines were used: AsPc-1, BxPC3,
Capan1, Colo357, Miapaca, Panc1, Su8686, and T3M4. QRT-PCR
was performed with the Light Cycler Fast Start DNA SYBR Green
Kit. Immunofluorescence of EGFR-GFP, actin and Eps8 was ana-
lysed by confocal microscopy. Cell motility was quantified by
the phagokinetic assay.
Results: QRT-PCR reveals that Eps8 expression is 4-fold increased
in pancreatic carcinoma compared to normal pancreatic tissue. In
pancreatic tissue, Eps8 is located apically in ductal epithelial cells.
In all eight pancreatic cell lines analysed, Eps8-expression corre-
lates with staging of the original tumors: cells derived from ascites
exhibit the strongest Eps8 expression, followed by cells from
metastases and primary tumors. In parallel, Eps8 expression in
cell lines is associated with increased cancer cell motility. Subcell-
ulary, Eps8 does not colocalize with the EGFR but is located at the
tip of actin filaments and at the leading cell edge.
Conclusion: Eps8 is increased in pancreatic cancer. Association
with dynamic actin at the leading cell edge in pancreatic cancer
cell lines seems to be an important mechanism for pancreatic
cancer cell migration promoting metastasis.
doi:10.1016/j.ejcsup.2006.04.069
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Background: Bone sialoprotein (BSP); an acidic glycoprotein that
plays a role in cancer cell growth, migration and invasion.
Methods: The expression, localisation and function of BSP in
chronic pancreatitis (CP) and pancreatic ductal adeno-carcinoma
